Milton S. Hershey Medical Center

NCT07812636

Early phase 1Not yet recruiting202615 people10 Sept 2026clinicaltrials.gov

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Phase 2Recruiting2026406 people7 Jan 2026clinicaltrials.gov

NCT06548490

Phase 2Recruiting2025200 people12 Aug 2024clinicaltrials.gov

NCT06369363

Early phase 1Not yet recruiting202620 people17 Apr 2024clinicaltrials.gov

Testing Interventions for Mobility Through Exercise (TIME)

No phaseActive, not recruiting2023702 people13 Feb 2023clinicaltrials.gov

NCT04199728

Phase 1/2Completed202127 people16 Dec 2019clinicaltrials.gov

NCT03229057

CollaboratorPhase 3Completed2018240 people25 Jul 2017clinicaltrials.gov

NCT03072147

CollaboratorPhase 2Completed201776 people7 Mar 2017clinicaltrials.gov

NCT02441842

Phase 4Completed200685 people12 May 2015clinicaltrials.gov

NCT02230332

Phase 2/3Completed201578 people3 Sept 2014clinicaltrials.gov

NCT01481233

Phase 2Withdrawn20130 people29 Nov 2011clinicaltrials.gov

NCT01248065

Phase 3Completed2011408 people25 Nov 2010clinicaltrials.gov

NCT01234974

Phase 2Withdrawn20100 people4 Nov 2010clinicaltrials.gov

NCT00907153

Phase 1/2Completed200936 people22 May 2009clinicaltrials.gov

NCT00837200

Phase 2Terminated200913 people5 Feb 2009clinicaltrials.gov

NCT00827567

Phase 2Terminated20096 people22 Jan 2009clinicaltrials.gov

NCT00712985

Phase 3Completed200518 people11 Jul 2008clinicaltrials.gov

NCT00704912

Phase 2Completed2008217 people25 Jun 2008clinicaltrials.gov

NCT00529542

Phase 2Completed200420 people14 Sept 2007clinicaltrials.gov

NCT00436761

Phase 1Status unknown200420 people19 Feb 2007clinicaltrials.gov